Loading…
Based on limited metadata with no full letter text available, Indigo Naturals, a drug manufacturer, received an FDA Warning Letter issued on April 6, 2020. While the specific violations cannot be determined from the available information, the letter indicates regulatory concerns significant enough to warrant formal FDA action regarding drug products. The warning was issued by the FDA's drug regulatory division, though the specific issuing office and detailed violation count are not documented in this metadata.